HETEROCYCLIC AMIDES USEFUL AS PROTEIN MODULATORS

Disclosed are compounds having the formula:wherein q, r, s, A, B, C, RA1, RA2, RB1, RB2, RC1, RC2, R3, R4, R5, R6, R14, R15, R16, and R17, are as defined herein, or a tautomer thereof, or a salt, particularly a pharmaceutically acceptable salt, thereof.

Saved in:
Bibliographic Details
Main Authors LIAN, Yiqian, RAMANJULU, Joshi M, ZHANG, Daohua, HUGHES, Terry V, DARCY, Michael G, KANG, Jianxing, ROMANO, Joseph J, LEISTER, Lara Kathryn, WANG, Gren Z, LI, Yue, DONG, Xiaoyang, DODSON, Jason W, MEHLMANN, John F, CHARNLEY, Adam Kenneth, NEVINS, Neysa, YE, Guosen
Format Patent
LanguageEnglish
Lithuanian
Published 26.09.2022
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed are compounds having the formula:wherein q, r, s, A, B, C, RA1, RA2, RB1, RB2, RC1, RC2, R3, R4, R5, R6, R14, R15, R16, and R17, are as defined herein, or a tautomer thereof, or a salt, particularly a pharmaceutically acceptable salt, thereof.
Bibliography:Application Number: LTIB2017051945T